Molecular Chaperones as Rational Drug Targets for Parkinson’s Disease Therapeutics

Por Kalia, S.K., Kalia, L.V., McLean, P.J.
Publicado em 2010

Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock in mice

Por Yue, M., Hinkle, K., Davies, P., Trushina, E., Fiesel, F., Christenson, T., Schroeder, A., Zhang, L., Bowles, E., Behrouz, B., Lincoln, S., Beevers, J., Milnerwood, A., Kurti, A., McLean, P. J., Fryer, J. D., Springer, W., Dickson, D., Farrer, M., Melrose, H.
Publicado no Neurobiol Dis (2015)